Position
Chief Development Officer
Company
ONL Therapeutics
Ann ArborBiotechnologyHealth CareBiopharmaDescription
ONL Therapeutics, Inc announced the appointment of Penny Fleck as chief development officer. In her new role, Ms Fleck will lead the development activities for the company’s lead asset, ONL1204 Ophthalmic Solution.
Quick answer
ONL Therapeutics Appoints Penny Fleck as Chief Development Officer (January 8, 2025). ONL Therapeutics is based in Ann Arbor, Michigan, United States.
- Who is the new Chief Development Officer at ONL Therapeutics?
- ONL Therapeutics named Penny Fleck Chief Development Officer, announced January 8, 2025.
- What did ONL Therapeutics announce on January 8, 2025?
- ONL Therapeutics, Inc announced the appointment of Penny Fleck as chief development officer. In her new role, Ms Fleck will lead the development activities for the company’s lead asset, ONL1204 Ophthalmic Solution.
- What does ONL Therapeutics do?
- ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to developing first-in-class therapeutics to protect and improve the vision of patients with retinal disease.
- Where is ONL Therapeutics based?
- ONL Therapeutics is based in Ann Arbor, Michigan, United States.
- Which similar companies made leadership changes around the same time?
- Centessa Pharmaceuticals plc (January 8, 2025), Tarsier Pharma (January 7, 2025), Verastem Oncology (January 15, 2025) and Oragenics (January 17, 2025) also announced leadership changes within 45 days of ONL Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Biopharma and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
- Verastem Oncology Appoints Matthew E. Ros as Chief Operating Officer (January 15, 2025)
- Oragenics Appoints Janet Huffman as Interim Chief Executive Officer (January 17, 2025)
- Arcus Biosciences Appoints Richard Markus, M.D., Ph.D., as Chief Medical Officer (January 21, 2025)
- Nurix Therapeutics appoints John Northcott as Chief Commercial Officer (January 22, 2025)
Who to call at ONL Therapeutics, and when
A new leader at ONL Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ONL Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ONL Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ONL Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ONL Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ONL Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.